Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
UnitedHealth earnings ease investor worries over flu season, stock up
-
Trilogy Metals Announces US$25 Million Bought Deal Offering of Common Shares
-
Novavax Announces Closing of Public Offering
-
Novavax Announces Closing of Public Offering
-
Novavax Announces Closing of Public Offering
-
PolarityTE Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriter’s Option
-
PolarityTE Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriter’s Option
-
PolarityTE Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriter’s Option
-
Cantor Fitzgerald Remains Bullish on Shire (SHPG) Following Announced Oncology Divestiture
-
Cantor Fitzgerald Reiterates Overweight on Horizon Pharma (HZNP)
-
Orchid Island Capital Announces April 2018 Monthly Dividend and March 31, 2018 RMBS Portfolio Characteristics
-
Cantor Remains Positive on Health Insurance Innovations (HIIQ) , Says Share Are 'Extremely Inexpensive'
-
PolarityTE (COOL) Prices 2.03M Common Stock Offering at $16/Share
-
PolarityTE Announces Pricing of Public Offering of Common Stock
-
PolarityTE Announces Pricing of Public Offering of Common Stock
-
Ur-Energy Provides 2018 Q1 Operational Results
-
UPDATE: Bellicum Pharmaceuticals (BLCM) PT Raised to $18 at Cantor Following FDA Lift of Clinical Hold on BPX-501 in US
-
Novavax (NVAX) Prices 30.3M Share Common Offering at $1.65/Sh
-
Novavax Prices Public Offering of Common Stock
-
Novavax Prices Public Offering of Common Stock
-
Novavax Prices Public Offering of Common Stock
-
PolarityTE (COOL) Reports Public Offering of Common Stock
-
PolarityTE Announces Public Offering of Common Stock
-
PolarityTE Announces Public Offering of Common Stock
-
UPDATE - Harvest Announces Executive Hires
-
Harvest Announces Executive Hires
-
ProPhotonix Honored by Vision Systems Design 2018 Innovators Awards Program
-
Tiberius Acquisition Corporation Common Stock And Warrants To Commence Trading Separately On April 10, 2018
-
Freddie Mac Prices $1 Billion Multifamily K-Deal, K-731
-
Cantor Fitzgerald Remains Bullish on Shire (SHPG)
-
UPDATE: Cantor Fitzgerald Downgrades NewLink Genetics (NLNK) to Neutral
-
ProPhotonix Limited - STKR - ProPhotonix Announces Holding(s) in Company
-
NewLink Genetics (NLNK) Defended at Cantor
-
Prophotonix Posts Notice Of Annual General Meeting
-
Paratek Pharmaceuticals (PRTK) PT Maintained at $50 at Cantor Fitzgerald on Omadacycline NDA Acceptance; 'Time to Make PRTK a Priority'
-
Strongbridge Biopharma (SBBP) 'Firing on All Cylinders' - Cantor Fitzgerald
-
ProPhotonix Limited Announces PDMR Shareholding
-
Cantor Highlights Square (SQ) From A Fundamental And Technical Basis
-
Rigel Pharmaceuticals (RIGL) PT Lowered to $6 at Cantor Fitzgerald Following Phase 2 Data
-
Celgene (CELG): COO Departure An Incremental Positive - Cantor Fitzgerald
-
Alkermes (ALKS) PT Lowered to $45 at Cantor Fitzgerald
-
Ur-Energy Announces Appointment of New Board Member: Rob Chang
-
Humana (HUM): Thoughts On Potential Walmart Acquisition - Cantor Fitzgerald
-
Acorda Therapeutics, Inc. (ACOR) PT Raised to $17 at Cantor Fitzgerald
-
Agile Therapeutics (AGRX) PT Lowered to $4 at Cantor Fitzgerald
-
Aldeyra Therapeutics (ALDX) PT Raised to $23 at Cantor Fitzgerald
-
Let The Shire (SHPG) Bidding War Begin - Cantor
-
Prometic Reports its Q4-2017 and YE-2017 Financial Results and Provides Update on Activities
-
Cantor Fitzgerald Starts Tahoe Resources (TAHO) at Buy
-
Tiberius Acquisition Corporation Announces Closing of Underwriters' Full Over-Allotment Option in Connection with its Initial Public Offering

